Figure 4.

Changes in blood eosinophilia following antifungal treatment. Blood eosinophil measurements assessed in (A) total subjects (N = 23), (B) never‐ (N = 11), and (C) ever‐smokers (N = 12). Measurements were recorded 4–16 weeks prior to initiation of therapy (Initial) and 4–16 weeks following (Follow up) initial antifungal therapy. Lines connecting data before and after antifungal therapy for the same patients. Data are presented as total blood eosinophils/dL with significance calculated using the Wilcoxon signed‐rank test.